INGRAO, LUCA
INGRAO, LUCA
Universita' degli Studi di MILANO
Effectiveness and safety of upadacitinib in juvenile idiopathic arthritis: beyond the polyarticular subset in pediatric and adult patients
2025 S. Costi, L. Ingrao, M.G. Lommano, G. Cincinelli, F. Baldo, A. Marino, R. Caporali, C.B. Chighizola
Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states— A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project
2025 C. Jauffret, A. Adinolfi, S. Sirotti, D. Cirillo, L. Ingrao, A. Lucia, E. Cipolletta, E. Filippucci, S. Tedeschi, R. Terkeltaub, N. Dalbeth, T. Pascart, G. Filippou
Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?–The time has come to reconsider the nomenclature of calcium pyrophosphate deposition
2025 S. Sirotti, C. Jauffret, A. Adinolfi, E. Cipolletta, D. Cirillo, L. Ingrao, A. Lucia, E. Filippucci, T. Pascart, S.K. Tedeschi, R. Terkeltaub, N. Dalbeth, G. Filippou
Expanding the expanded risk score to psoriatic arthritis: any port in a storm
2025 E.G. Favalli, L. Ingrao, G. Trignani, M. Ferrito, G. Cincinelli, R. Caporali